Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

453.06

+4.77 (1.06%)

At close: May 13, 2026, 4:00 PM EDT

448.46

-4.60 (-1.01%)

Pre-market: May 14, 2026, 6:10 AM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Trikafta / Kaftrio Revenue	10.13B	10.31B	10.24B
Trikafta / Kaftrio Revenue Growth	-1.75%	0.72%	14.47%
Alyftrek Revenue	1.21B	837.80M	-
Alyftrek Revenue Growth	44.22%	-	-
Casgevy Revenue	144.50M	115.80M	10.00M
Casgevy Revenue Growth	24.78%	1058.00%	-
Journavx Revenue	87.30M	59.60M	-
Journavx Revenue Growth	46.48%	-	-
Other Product Revenue	-	820.10M	781.50M
Other Product Revenue Growth	-	4.94%	-15.47%
Net Product Revenue	12.20B	11.97B	11.02B
Net Product Revenue Growth	1.89%	8.63%	11.66%
Other Collaborative and Royalty Revenue	-	30.70M	-
Revenue (Total)	12.22B	12.00B	11.02B
Revenue (Total) Growth	1.81%	8.90%	11.66%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Other Collaborative and Royalty Revenue	-	30.70M	-
United States Product Revenue	7.67B	7.55B	6.68B
United States Product Revenue Growth	1.62%	12.92%	10.67%
Outside of United States Product Revenue	4.56B	4.45B	4.34B
Outside of United States Product Revenue Growth	2.34%	2.71%	13.23%
Revenue (Other)	-10.00M	-30.70M	-
Revenue (Total)	12.22B	12.00B	11.02B
Revenue (Total) Growth	1.81%	8.90%	11.66%

Updated May 5, 2026. Data Source: Fiscal.ai.